Skip to main content

Month: September 2024

UPDATE — ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

The new AirTouch™ N30i tube-up nasal mask for CPAP combines softness, breathability, and a high-performance, durable seal to provide exceptional comfortATN30iAirTouch N30iSAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ResMed first in CPAP (continuous positive airway pressure) mask innovation with the launch of the AirTouch™ N30i. Designed to create a natural and comfortable sleep experience for users, the AirTouch N30i is a fabric-wrapped frame featuring a soft, breathable, and moisture-wicking design for optimal comfort in a tube-up design. Sleep apnea affects more than 54 million people in the United States and nearly one billion people worldwide1. This...

Continue reading

Change to Financial Calendar 2024

Company announcement no. 19/2024Columbus A/S has changed the release date of the Interim Report Q3 2024 from 7 November 2024 to 5 November 2024, approximately at 9:30 am CET. After publication of financial statements the Company will conduct an investor presentation via a conference call and webcast. For details regarding the conference calls, please see the Company’s website: https://ir.columbusglobal.com/calendar-and-events Ib Kunøe                        Søren Krogh KnudsenChairman of the Board                CEO & PresidentFor further information, please contact: CEO & President, Søren Krogh Knudsen, +45 70 20 50 00AttachmentSE_19_2024_Updated_Financial_calendar_2024

Continue reading

Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting

Responder Analyses Show Treatment with Aficamten Demonstrated Improvements on Multiple Assessments of Clinical Significance to Cardiologists Results Simultaneously Published in the Journal of the American College of Cardiology SOUTH SAN FRANCISCO, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that additional analyses synthesizing data from SEQUOIA-HCM (Safety, Efficacy, and Quantitative Understanding of Obstruction Impact of Aficamten in HCM), the pivotal Phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM), were presented virtually at the Heart Failure Society of America (HFSA) Annual Scientific Meeting by Martin Maron, M.D., Director of the Hypertrophic Cardiomyopathy Center at the Lahey Hospital and Medical Center....

Continue reading

Highwoods Reports No Notable Damage from Hurricane Helene

RALEIGH, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) — Highwoods Properties, Inc. (NYSE:HIW) reports after having conducted a thorough assessment of its Florida, Georgia, North Carolina and Tennessee properties that its buildings have not sustained any notable damage. Ted Klinck, President and CEO stated, “We are fortunate all members of the Highwoods family are safe. Our team did terrific work preparing for the hurricane and we are thankful to have fared so well. Our thoughts and prayers are with all those who have been hit hard by this storm and need support from our greater community.” About Highwoods Highwoods Properties, Inc., headquartered in Raleigh, is a publicly-traded (NYSE:HIW), fully-integrated office real estate investment trust (“REIT”) that owns, develops, acquires, leases and manages properties primarily in the best business...

Continue reading

Form 8.3 – Learning Technologies Group plc – Octopus Investments

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Full name of discloser: OCTOPUS INVESTMENTS LTD(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Learning Technologies Group plc(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)        Date position...

Continue reading

InspireSemi Provides Business Update and Announces CFO Transition

VANCOUVER, British Columbia and AUSTIN, Texas, Sept. 30, 2024 (GLOBE NEWSWIRE) — Inspire Semiconductor Holdings Inc. (TSXV: INSP) (“Inspire” or the “Company”), a chip design company that provides revolutionary high-performance, energy-efficient accelerated computing solutions for High Performance Computing (HPC), AI, graph analytics, and other compute-intensive workloads, is pleased to announce that today it is providing a general business update by live webinar at 1:00 p.m. (Eastern Time) Key topics the business update covers include:Recent key accomplishments and progress on product developmentCompany plans going forwardThe recently closed C$10M convertible loan financing. See press release dated September 23, 2024 for further detailsThe proposed delisting of the Company’s shares from the TSX Venture Exchange (the “Delist”)Change...

Continue reading

Territorial Bancorp Board Reaffirms Its Commitment to Proposed Merger with Hope Bancorp

Again Rejects Blue Hill Proposal as Remaining Highly Uncertain, Inferior to Hope Merger Agreement and Unlikely to Benefit Territorial Shareholders HONOLULU, Sept. 30, 2024 (GLOBE NEWSWIRE) — Territorial Bancorp Inc. (“Territorial”) again reaffirmed the commitment of its Board of Directors to the proposed merger with Hope Bancorp, Inc. (“Hope”) that was announced on April 29, 2024. The announcement was made in response to additional information provided to Territorial from, and further information released by, Blue Hill Advisors LLC (“Blue Hill”) on September 26, 2024 regarding the Hope merger and the proposal by unidentified investors and Blue Hill (the “Blue Hill Group”). “While the latest Blue Hill Group information indicates an increase in their offer by 4%, the proposal continues to leave so many unanswered questions, such...

Continue reading

Viper Networks Provides Update on the Acquisition of the Telecommunications Assets of Hammer Fiber Optic Holdings Corp

TROY, Mich., Sept. 30, 2024 (GLOBE NEWSWIRE) — Viper Networks (OTCPK: VPER) has applied for the necessary regulatory approvals from the Federal Communications Commission and various state authorities in order to complete the acquisition of the telecommunications assets of Hammer Fiber Optics Holdings Corp. The acquisition includes Endstream Communications, LLC and 1stPoint Communications, LLC and all of its subsidiaries. The closing date is anticipated to be in the fourth quarter of this year, subject to obtaining regulatory approval. “We are very pleased with the progress we are making toward closing the acquisition,” said Erik Levitt, CEO of 1stPoint Communications and Endstream Communications. “We anticipate being able to complete the process in the timeframes originally contemplated by management and Viper’s Board of Directors.” With...

Continue reading

TransPerfect Acquires Paybooks Technologies

TransPerfect Acquires India-Based Paybooks TechnologiesTransPerfect has acquired India-based Paybooks Technologies.NEW YORK and BANGALORE, India, Sept. 30, 2024 (GLOBE NEWSWIRE) — TransPerfect, the world’s largest provider of language and AI solutions for global business, today announced that it has acquired India-based Paybooks Technologies, a leading provider of HR, payroll, and compliance solutions that enable organizations to easily onboard, manage, and optimize international workforces. Financial terms of the transaction were not disclosed. Paybooks is a rapidly growing technology and service provider that offers a cloud-based, all-in-one HR and payroll system that enables enterprise customers to seamlessly manage the full employee lifecycle. From recruiting and onboarding to payroll processing, reimbursements, benefits,...

Continue reading

Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules

SALT LAKE CITY, Sept. 30, 2024 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly-owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurological diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that on September 30, 2024 it entered into a securities purchase agreement with a healthcare focused institutional investor (“Healthcare Investor”) for the issuance and sale of 742,626 shares of its common stock (or pre-funded warrants in lieu thereof) in a registered direct offering priced at market under Nasdaq rules. In a concurrent private placement, Clene also agreed to issue to the Healthcare Investor warrants to purchase...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.